Every recall we track for The Harvard Drug Group, LLC — 10 in all — plus the complaints and injury reports the public filed about them.
Harvard Drug Group recalls methylergonovine maleate tablets (0.2 mg) with subpotent drug risk. Affected lots expire 09/2026 to 08/2027. Consumers should contact the manufacturer for details.
Harvard Drug Group recalls Omega-3 Acid Ethyl Esters capsules due to failed stability testing for loss on drying. This may affect product quality but does not pose immediate safety risks.
Harvard Drug Group recalls 7mg Memantine Hydrochloride Extended-Release capsules due to failed dissolution specifications. This may affect medication effectiveness. Contact for return instructions.
Harvard Drug Group recalls 50-tablet Midodrine hydrochloride tablets with inadequate blister packaging sealing. This could lead to tablet exposure to moisture or contaminants.
Harvard Drug Group recalls specific lots of 100mg Gabapentin Capsules (Rx only) due to failed impurities during stability testing. Consumers should contact the manufacturer for details.
Harvard Drug Group recalls 100mg Gabapentin Capsules (10 per blister) with potential impurities from stability testing. Affected lots expire 02/2026 to 01/2027. No specific remedy provided in recall notice.
Harvard Drug Group recalls 100mg Gabapentin Capsules (NDC 55154-3363-0) with defective blister packaging that may not seal properly. Affected lots M05205A and M05205B expire 10/2026.
Harvard Drug Group recalls 100mg Gabapentin Capsules (100-count blister packs) because the packaging may not seal properly. This could lead to contamination or exposure to air. Consumers should contact the manufacturer for details.
Harvard Drug Group recalls Thera Tablets with Beta Carotene dietary supplements that have missing labeling on blister packs. This affects specific lot numbers and may lead to confusion about product information.
